Fragility hip fracture: improving patient outcomes by reducing risk of future fractures
Abstract
Leicester Hospitals admit over 850 cases of fragility hip fracture annually. 25% of patients will suffer another fracture in the 5 years following their fragility hip fracture. Intravenous Zoledronate is recommended as a first line treatment option to reduce fracture risk. In 2023 our hospitals performance in the National hip fracture database (NHFD) showed we were significantly below the national average in secondary fracture prevention and patient follow-up at 120 days. (UHL data 2023 24.9% vs. national average 45.3%). This project sought to embed the use of intravenous zoledronate in our perioperative pathway and improve 120 day follow up.
Introduced a new guideline for rapid loading of Vitamin D and administration of intravenous Zoledronate. Conducted teaching sessions and disseminated our guideline with all stakeholders. A standardised checklist was introduced and Royal Osteoporosis Society patient information leaflets given to all patients. Utilised our hospitals new text messaging system (accuryx) to design a post discharge questionnaire to explore patients’ experience of our service.
Our data from the NHFD has shown a significant improvement from 24.9% of patients in 2023 receiving appropriate bone protection treatment to 69% in 2025. Utilising accuryx we have gained valuable feedback from patients with a response rate of 27%.
Changing practice required education of staff and the introduction of a new guideline into our established pathway. Patients treated with…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.